Medical food or dietary supplement: test your product against the US definition first
First test the product against the medical-food definition. Separately, all five 101.9(j)(8) conditions are required for the exemption from 101.9 nutrition labeling; other labeling and claims rules still apply.
In Short
- The definition decides, not the market.
- Labeling exemption needs all five conditions.
- Choose one route; don't mix two.
Brands making products for rare diseases and specialised nutrition often ask if a product can be a medical food rather than a dietary supplement. In US law the term is defined narrowly in 21 U.S.C. 360ee(b)(3), and 21 CFR 101.9(j)(8) sets five conditions for the medical food exemption from standard nutrition labelling. Only those two texts were opened. FDA medical foods guidance, EU rules for food for special medical purposes and orphan drug designation were not reviewed. This guide is orientation, not legal advice. Sources checked 5 Oct 2026.
What the statute says a medical food is
Section 5(b)(3) of the Orphan Drug Act, codified at 21 U.S.C. 360ee(b)(3), defines a medical food as a food formulated to be consumed or administered enterally under the supervision of a physician, and intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.
More on what the statute says a medical food is
Each phrase is a question your file has to answer with evidence. Words such as rare disease or orphan in your marketing do not create medical food status; the definition does.
The five conditions in 21 CFR 101.9(j)(8)
The nutrition labelling rule exempts medical foods only if all five conditions are met: (i) a specially formulated and processed product, not a naturally occurring food used in its natural state, for partial or exclusive feeding by mouth or tube; (ii) for a patient who has limited or impaired capacity to ingest, digest, absorb or metabolize ordinary foods or certain nutrients, or other special medically determined nutrient requirements that a modified normal diet alone cannot manage; (iii) nutritional support specifically modified for the unique needs of the disease or condition; (iv) intended for use under medical supervision; and (v) only for a patient receiving active and ongoing medical supervision.
101.9(j)(8) nutrition-labeling exemption: all five required
Choosing a route, not mixing two
A product positioned as a dietary supplement and one positioned as a medical food are labelled and marketed under different rules. Supplement labelling and manufacturing rules (21 CFR 101.36 and Part 111) were not reopened for this guide.
Three positioning questions (invented products)
- Distinctive requirement must be established by medical evaluation.
- Record the evidence for each condition.
- Regulatory team decides.
More on choosing a route, not mixing two
The practical risk is a label, website or sales sheet that borrows language from both. Write down which route you are using and why. If the evidence for any of the five conditions is thin, treat that as a decision for your regulatory team, not a copywriting problem to solve later.
Building the Evidence File
Map each element of the definition and each 101.9(j)(8) condition to a document you can show. Typical evidence includes the formulation specification and its version, the intended patient population, the medical evaluation that establishes the distinctive nutritional requirement, how the product reaches patients under supervision, and the label and directions for use.
Worked Example: Evidence File for Formula MF-204
| Element | Evidence | Owner |
|---|---|---|
| Distinctive nutritional requirement | Medical evaluation references, dated | Medical affairs |
| Specially formulated (j)(8)(i) | Formula spec MF-204 rev C | Product development |
| Supervision (j)(8)(iv)-(v) | Supply model and directions for use | Regulatory |
| Label | Label rev 4 linked to rev C | Regulatory and quality |
- Distinctive nutritional requirement
- Evidence
- Medical evaluation references, dated
- Owner
- Medical affairs
- Specially formulated (j)(8)(i)
- Evidence
- Formula spec MF-204 rev C
- Owner
- Product development
- Supervision (j)(8)(iv)-(v)
- Evidence
- Supply model and directions for use
- Owner
- Regulatory
- Label
- Evidence
- Label rev 4 linked to rev C
- Owner
- Regulatory and quality
More on building the Evidence File
Keep the file versioned: when a formula changes, the label, the claims and the rationale should be reviewed together, with a named person approving each revision.
What else to check, and what this guide did not
Other rules can treat medical foods differently. California's packaging law, for example, excludes packaging for medical food as defined in 21 U.S.C.
More on what else to check, and what this guide did not
360ee(b)(3) from its definition of covered material (Public Resources Code 42041). This guide did not open FDA's guidance on medical foods, FDA's compliance programme, state law, or the EU framework for food for special medical purposes (Regulation (EU) No 609/2013). Check each market's own texts before you decide how to position a product there.
Questions
Does saying a product is for a rare disease make it a medical food?
No. Status depends on the statutory definition in 21 U.S.C. 360ee(b)(3), not on marketing language. The disease or condition must have distinctive nutritional requirements established by medical evaluation.
Are medical foods exempt from nutrition labelling?
21 CFR 101.9(j)(8) exempts a medical food from the nutrition labelling requirements of section 101.9 only if all five listed conditions are met. Other labelling rules were not reviewed in this guide.
Can a medical food be sold without medical supervision?
The definition refers to physician supervision, and 101.9(j)(8)(iv) and (v) refer to medical supervision and a patient receiving active and ongoing supervision. How a sales channel meets that is a decision for your regulatory team.
Does V5 decide whether a product is a medical food?
No. V5 keeps formula versions, label versions and supporting documents linked with approval history. Your regulatory team decides positioning and approves each label.
Practical orientation, not legal advice. Rules differ by jurisdiction; your quality and compliance team decides what applies.
Keep reading
EU Novel Food Regulation (EU) 2015/2283 for Supplement Ingredients
Israel MoH Supplement, Food & Medical Device Readiness Guide
Minor Cannabinoids & Nootropics: Supplement Positioning
Pet Food and Animal Food cGMP Readiness: 21 CFR 507
10 CFR Part 35 Medical Use: Written Directives, Dosage Records and Medical Events
21 CFR 111 Readiness: Identity, Master and Batch Records